What does ProteoFormiX do?

ProteoFormiX is a research organisation in Vorselaar. Private Limited, started on 31 July 2017, 1 establishment.

What is the address of ProteoFormiX?

The registered office of ProteoFormiX is located at Sassenhout 26 C, 2290 Vorselaar.

Is ProteoFormiX still active?

Yes. According to the CBE (30 October 2026) ProteoFormiX is active, legal situation “Normale toestand”, started on 31 July 2017.

Is ProteoFormiX registered on Peppol?

Yes, ProteoFormiX is registered on the Peppol network with ID 0208:0678992278.

What is the enterprise number of ProteoFormiX?

The enterprise number of ProteoFormiX is BE0678992278.

When was ProteoFormiX founded?

ProteoFormiX was founded on 31 July 2017.

Who are the directors of ProteoFormiX?

According to the 2025 annual accounts, the directors of ProteoFormiX are: Peter Verhaert.

Is ProteoFormiX a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 31 July 2017; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did ProteoFormiX make in 2025?

ProteoFormiX recorded a loss after taxes of € 35,284 in financial year 2025.

What is the revenue of ProteoFormiX?

As a small company, ProteoFormiX is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -4,642.

ProteoFormiX (Private Limited) - Vorselaar - BE0678992278

Dossier ProteoFormiX, printed on 30 October 2026 from databakkes.be/en/0678992278/proteoformix. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 4 of the last 4 fiscal years.
Two loss years in a row NBB

Negative result in 2024 and 2025.
Tight liquidity NBB

Cash and receivables cover 17 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

ProteoFormiX from Vorselaar, company number BE0678992278, closed financial year 2025 with a result of € -35,284 after tax. For that financial year ProteoFormiX recorded a gross margin of € -4,642 and equity of € -188,614. Compared with financial year 2024, the result moved from € -7,187 to € -35,284. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 11, 2026.

What it is worth Caution

€ -188,614

▼ € 35,284 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -35,284

▼ 391 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 3,015

▼ 73% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -307,163.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Wage cost estimate Staff cost at a one-person company Staff Only people on the payroll count here.€ 185 Likely the director’s social contribution or pension premium.The director’s pay Already netted into the gross margin, not shown separately in the accounts. Typical for one-person companies € 45,000 gross per year minimum for the reduced tax rate≈ € 2,100 net per month after contributions, tax and usually some benefits in kind, roughly Assumption based on the chart of accounts, not a figure from the source.

€ 185

▲ 233% vs 2024

No payroll staff. An amount this small is usually a social contribution or pension premium for the director, booked under staff costs.

Vehicles and equipment

€ 8,448

▲ 236% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 31,089

▲ 38% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 5,774

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -130,278 Gross margin 2022: € -130,278 First fiscal year in the series	€ -9,351 Gross margin 2023: € -9,351 ▲ € 120,928 vs 2022 (€ -130,278) Favourable step	€ 23,082 Gross margin 2024: € 23,082 ▲ € 32,433 vs 2023 (€ -9,351) Favourable step	€ -4,642 Gross margin 2025: € -4,642 ▼ € 27,724 vs 2024 (€ 23,082) Unfavourable step	▼ € 27,724
Profit after taxes	€ -179,693 Profit after taxes 2022: € -179,693 First fiscal year in the series	€ -41,697 Profit after taxes 2023: € -41,697 ▲ € 137,997 vs 2022 (€ -179,693) Favourable step	€ -7,187 Profit after taxes 2024: € -7,187 ▲ € 34,510 vs 2023 (€ -41,697) Favourable step	€ -35,284 Profit after taxes 2025: € -35,284 ▼ € 28,097 vs 2024 (€ -7,187) Unfavourable step	▼ € 28,097
Equity	€ -104,446 Equity 2022: € -104,446 First fiscal year in the series	€ -146,143 Equity 2023: € -146,143 ▼ € 41,697 vs 2022 (€ -104,446) Unfavourable step	€ -153,330 Equity 2024: € -153,330 ▼ € 7,187 vs 2023 (€ -146,143) Unfavourable step	€ -188,614 Equity 2025: € -188,614 ▼ € 35,284 vs 2024 (€ -153,330) Unfavourable step	▼ € 35,284
Total debts	€ 295,970 Total debts 2022: € 295,970 First fiscal year in the series	€ 318,148 Total debts 2023: € 318,148 ▲ 7% vs 2022 (€ 295,970) Unfavourable step	€ 329,069 Total debts 2024: € 329,069 ▲ 3% vs 2023 (€ 318,148) Unfavourable step	€ 371,431 Total debts 2025: € 371,431 ▲ 13% vs 2024 (€ 329,069) Unfavourable step	▲ 13%
Cash	€ 3,655 Cash 2022: € 3,655 First fiscal year in the series	€ 18,874 Cash 2023: € 18,874 ▲ € 15,218 vs 2022 (€ 3,655) Favourable step	€ 11,379 Cash 2024: € 11,379 ▼ 40% vs 2023 (€ 18,874) Unfavourable step	€ 3,015 Cash 2025: € 3,015 ▼ 73% vs 2024 (€ 11,379) Unfavourable step	▼ 73%
Retained profit	€ -222,995 Retained profit 2022: € -222,995 First fiscal year in the series	€ -264,692 Retained profit 2023: € -264,692 ▼ € 41,697 vs 2022 (€ -222,995) Unfavourable step	€ -271,879 Retained profit 2024: € -271,879 ▼ € 7,187 vs 2023 (€ -264,692) Unfavourable step	€ -307,163 Retained profit 2025: € -307,163 ▼ € 35,284 vs 2024 (€ -271,879) Unfavourable step	▼ € 35,284
Bank debt	€ 149,000 Bank debt 2022: € 149,000 First fiscal year in the series	€ 149,000 Bank debt 2023: € 149,000 Unchanged (€ 149,000) Unchanged	€ 149,000 Bank debt 2024: € 149,000 Unchanged (€ 149,000) Unchanged	€ 0 Bank debt 2025: € 0 ▼ 100% vs 2024 (€ 149,000) Favourable step	▼ 100%
Balance sheet total	€ 191,523 Balance sheet total 2022: € 191,523 First fiscal year in the series	€ 172,005 Balance sheet total 2023: € 172,005 ▼ 10% vs 2022 (€ 191,523) Unchanged	€ 175,739 Balance sheet total 2024: € 175,739 ▲ 2% vs 2023 (€ 172,005) Unchanged	€ 182,817 Balance sheet total 2025: € 182,817 ▲ 4% vs 2024 (€ 175,739) Unchanged	▲ 4%

Key figures of ProteoFormiX, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to ProteoFormiX?

What happened at ProteoFormiX in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 11, 2026 New annual accounts for financial year 2025: loss of € 35,284. Source: NBB ↗
Jul 31, 2017 New establishment in Vorselaar. KBO
Jul 31, 2017 Start of the company according to the CBE. KBO

In short

From € 179,693 loss in 2022 to € 35,284 loss in 2025.

Paid € 16 in corporate taxes since 2022.

Original PDFs at the National Bank ↗

Management

Peter Verhaert

ProteoFormiX

Behind ProteoFormiX is Peter Verhaert.

Directors

According to the 2025 annual accounts

Peter Verhaert

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Sassenhout 26 C

2290 Vorselaar

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0678.992.278

VAT number

BE 0678.992.278

Registered office

Sassenhout 26 C, 2290 Vorselaar

Names & denominations

ProteoFormiX

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

31 July 2017

Peppol

Active · Active since 24 Nov 2023

Contact

[email protected]

Activities · NACE

Speur- en ontwikkelingswerk op biotechnologisch gebied

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering

View on CBE Public ↗ Annual accounts (NBB) ↗

ProteoFormiX

Warning lights

Financials

What happened to ProteoFormiX?

Management

Directors

Establishments

Establishment units

Details

Frequently asked questions